university-of-manitoba-clinical-pharmacology-lab.png

Principle Investigator

Dr. Lauren E Kelly, PhD, MSc, CCRP, Department of Pharmacology and Therapeutics, Rady Faculty of Heath Sciences, University of Manitoba

Co-Investigators

Dr. Christine Leong, PharmD, PhD, College of Pharmacy

Dr. Geert ‘t Jong, MD, PhD, Department of Pediatrics and Child Health

Research Program:       

Screen Shot 2021-10-05 at 8.40.26 PM.png

Dr. Kelly’s research program includes clinical research studies on the safety and efficacy of drugs used in pediatric and perinatal populations. Dr. Kelly leads a pan-Canadian Clinical Trials Training Platform, called Increasing capacity for Maternal and Paediatric Clinical Trials, known as IMPaCT. She is also the Scientific Director for the Canadian Collaborative for Childhood Cannabinoid Therapeutics, C4T.

As an expert in pediatric clinical trials and pharmacovigilance, Dr. Kelly has advisory roles with KidsCAN Trials, RareKids-CAN, and Conect4Children in Europe. Dr. Kelly is a former member of the Scientific Advisory Committee on Health Products Containing Cannabis at Health Canada, co-led of the Canadian Medical Cannabis trials Network and a current member of the Canadian Consortium for the Investigation of Cannabinoids Board of Directors.